Halozyme Therapeutics, Inc.

Ownership Transactions Reported by 14 Insiders

Symbol
HALO on Nasdaq
Location
12390 El Camino Real, San Diego, CA

Insiders trading volume in the past year

Halozyme Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Helen Torley PRESIDENT AND CEO, Director $46.7M -$6.26M -11.8% Feb 15, 2025
Michael J. LaBarre Svp, Chief Technical Officer $12.6M -$8.45M -40.2% Feb 15, 2025
Connie Matsui Director $9.87M Nov 29, 2024
Matthew L. Posard Director $4.15M -$2.7M -39.4% Aug 12, 2024
Mark Howard Snyder Svp, Chief Legal Officer $2.84M Feb 16, 2025
Nicole LaBrosse Svp, Chief Financial Officer $2.76M -$1.83M -39.8% Feb 15, 2025
Jean Pierre Bizzari Director $2.56M May 5, 2023
Jeffrey W. Henderson Director $2.3M -$782K -25.4% Feb 3, 2025
Bernadette Connaughton Director $1.92M Apr 25, 2024
Masaru Matsuda SVP, General Counsel $1M Sep 4, 2021
Akiko Moni Miyashita Director $922K Apr 25, 2024
James M. Daly Director $738K Aug 11, 2023
Barbara Gayle Duncan Director $728K Apr 25, 2024
Mahesh Krishnan Director $372K Apr 25, 2024

Recent Insider Transactions by Companies or Individuals for Halozyme Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.